Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption

Abstract

In order to inhibit the growth of lung cancer bone metastasis and reduce the bone resorption at bone metastasis sites, a bone metastasis target micelle DOX@DBMs-ALN was prepared. The size and the zeta potential of DOX@DBNs-ALN were about 60 nm and -15 mV, respectively. DOX@DBMs-ALN exhibited high binding affinity with hydroxyapatite and released DOX in redox-responsive manner. DOX@DBMs-ALN was effectively up taken by A549 cells and delivered DOX to the nucleus of A549 cells, which resulted in strong cytotoxicity on A549 cells. The in vivo experimental results indicated that DOX@DBMs-ALN specifically delivered DOX to bone metastasis site and obviously prolonged the retention time of DOX in bone metastasis site. Moreover, DOX@DBMs-ALN not only significantly inhibited the growth of bone metastasis tumour but also obviously reduced the bone resorption at bone metastasis sites without causing marked systemic toxicity. Thus, DOX@DBMs-ALN has great potential in the treatment of lung cancer bone metastasis.

Efficacy Evaluation of Zoledronic Acid Combined with Chemotherapy in the Treatment of Lung Cancer Spinal Metastases on Computed Tomography Images on Intelligent Algorithms

“…Quantitative Evaluation. The maximum a posteriori Bayesian (MAPB) method [17], the sparse regularized Poisson denoising (SRPD) algorithm [18], and the wavelet packet transform (WPT) denoising algorithm [19] were introduced into the text, which was quantitatively compared with the OMAPB algorithm proposed in this study. Peak signal to noise ratio (PSNR) and Mean Structure Similarity (MSSIM) were used as evaluation indicators.…”

Catalpol Protects Against High Glucose-Induced Bone Loss by Regulating Osteoblast Function

“…The hyperglycemic conditions induce the accelerated formation and accumulation of AGEs, which directly inhibits osteoblasts and upregulates sclerostin in osteocytes. In addition, the high-glucose level increases the secretion levels of sclerostin in osteocytes and further inhibits osteoblasts by suppressing the Wnt/β-catenin pathway (Ye et al, 2018). In this study, type 2 diabetic mice showed significant inhibition of bone formation, and high glucose significantly inhibited the differentiation and migration of MC3T3-E1 cells.…”

Macrophage-Targeted Dextran Sulfate-Dexamethasone Conjugate Micelles for Effective Treatment of Rheumatoid Arthritis

“…The micelles were prepared by dialysis method [ 38 ]. First, the DS-cad-DXM and DXM were dissolved into the DMSO and then slowly added into the deionized water with vigorous stirring.…”